Argus
•
Apr 29, 2026
RMD: Lowering target price to $239.00
Summary
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Stryker Corporation
May 01, 2026
•
SYK
Analyst Report: Verisk Analytics, Inc.
Apr 29, 2026
•
VRSK
Analyst Report: Zimmer Biomet Holdings, Inc.
Apr 29, 2026
•
ZBH
XRAY: Lowering target price to $11.00
Apr 29, 2026
•
XRAY
IDXX: Lowering target price to $625.00
Apr 29, 2026
•
IDXX
